Ads
related to: drug relapse rates
Search results
A second animal tranquilizer has infiltrated the state's street drugs, making deadly mark
Detroit Free Press· 5 hours agoLike xylazine before it, the new drug, medetomidine, is a non-opioid animal tranquilizer that is not...
Colorectal cancer: Immunotherapy drug may help patients avoid surgery
Medical News Today· 12 hours agoPast research shows that treating MMR deficient/MSI-High colorectal cancer tumors can sometimes be...
Weight-loss injections could halve risk of cancer
The Telegraph via Yahoo News· 2 days agoRong Xu, professor of biomedical informatics and director of CWRU’s centre for artificial intelligence in drug discovery said it was an observational...
AbbVie (ABBV) Starts Late-Stage Study on Multiple Myeloma Drug
Zacks via Yahoo Finance· 11 hours agoThe late-stage study will evaluate AbbVie's (ABBV) experimental antibody to treat patients with ...
Biotech Stock Roundup: GSK's Litigation Update, BIIB's Drug Approval & Other Updates
Zacks via Yahoo Finance· 9 hours agoAll key secondary endpoints (annualized flare rate; flare-free, treatment-free complete remission;...
AbbVie treats first subject in Phase III multiple myeloma drug trial
Clinical Trials Arena via Yahoo Finance· 18 hours agoOverall survival, complete response or better, very good partial response or better, the rate of...
Blenrep-Based Regimen Yields PFS Benefit in Relapsed/Refractory Myeloma
MedPage Today· 5 days agoAt a median follow-up of 21.8 months, the 12-month estimated PFS rates were 71% with BPd versus 51%...
Drug already available on NHS could help cure deadly form of bowel cancer
Daily Telegraph· 4 days agoPembrolizumab works by blocking the action of a molecule called PD-1 that hides the cancer from the...
Bristol Myers Squibb’s Breyanzi gains FDA approval for lymphoma
Pharmaceutical Technology via Yahoo Finance· 7 days agoSquibb (BMS) has received approval from the US Food and Drug Administration for Breyanzi...
GSK blood cancer drug nearly halves risk of death in late-stage trial
Reuters via Yahoo News· 5 days agoGSK's multiple myeloma drug Blenrep nearly halved the risk of disease progression or death compared...